Incidence of second primary cancers after radiotherapy combined with platinum and/or cetuximab in head and neck cancer patients.

Olgun EliçinBurim SermaxhajBeat BojaxhiuMohamed ShelanRoland GigerDaniel RauchDaniel M Aebersold

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2018)

The Switch strategy may expose the patients to an increased risk of developing SPC. The use of switch should be advocated with caution until robust pre-clinical and clinical data are available.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
radiation therapy
early stage
big data
artificial intelligence
rectal cancer
patient reported